Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 3Lymphoma, Follicular 2Leukemia 2Waldenstrom Macroglobulinemia 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, AIDS-Related 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1HIV Infections 1

Interventions

Rituximab 57Cyclophosphamide 42fludarabine phosphate 29Peripheral Blood Stem Cell Transplantation 29Mycophenolic Acid 22Dexamethasone 21Tacrolimus 20Whole-Body Irradiation 18Bortezomib 18Cyclosporine 15Busulfan 13ibrutinib 12Methotrexate 12Melphalan 12Radiotherapy 11Etoposide 11Antilymphocyte Serum 10zanubrutinib 9Calcium Dobesilate 9venetoclax 7Sirolimus 7idelalisib 6Prednisone 6Lenalidomide 6Filgrastim 6Doxorubicin 6Cyclosporins 6Bendamustine Hydrochloride 6Alemtuzumab 6sargramostim 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Waldenstrom Macroglobulinemia × VAP-cyclo protocol × Clear all
NCT00003784 2013-01-24

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
102 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡